Published in Arch Gen Psychiatry on July 01, 2006
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
Learning From Animal Models of Obsessive-Compulsive Disorder. Biol Psychiatry (2015) 2.07
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther (2011) 1.71
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav (2011) 1.29
Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Mol Psychiatry (2014) 1.29
The pathophysiology of restricted repetitive behavior. J Neurodev Disord (2009) 1.24
Gestational exposure to low dose bisphenol A alters social behavior in juvenile mice. PLoS One (2011) 1.21
Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci (2014) 1.19
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol (2012) 1.19
A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry (2009) 1.16
Neurexin and neuroligin mediate retrograde synaptic inhibition in C. elegans. Science (2012) 1.13
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology (2013) 1.08
A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder. Biol Psychiatry (2012) 1.07
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review. Neuropsychiatr Dis Treat (2009) 1.06
Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry (2012) 1.06
Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry (2011) 1.06
Brain imaging in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.06
Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest (2010) 1.04
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res (2009) 1.03
Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample. Autism Res (2008) 0.98
Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med (2008) 0.97
Family-based genetic association study of DLGAP3 in Tourette Syndrome. Am J Med Genet B Neuropsychiatr Genet (2010) 0.97
Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment. Adv Med (2014) 0.97
Genetics of early-onset obsessive-compulsive disorder. Eur Child Adolesc Psychiatry (2010) 0.97
Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol (2013) 0.97
Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics. Autism Res (2009) 0.96
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder. Curr Chem Genomics (2008) 0.95
The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci (2010) 0.95
Genome-wide linkage using the Social Responsiveness Scale in Utah autism pedigrees. Mol Autism (2010) 0.95
Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philos Trans R Soc Lond B Biol Sci (2013) 0.94
Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 0.93
Children with obsessive-compulsive disorder: are they just "little adults"? J Clin Invest (2009) 0.92
Genetics of obsessive-compulsive disorder. Psychiatr Clin North Am (2010) 0.90
Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biol Psychiatry (2007) 0.90
Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder. Neuropsychopharmacology (2011) 0.90
Genetic and environmental influences on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci (2008) 0.90
N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. Clin Psychopharmacol Neurosci (2015) 0.90
12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder. Neuropsychopharmacology (2013) 0.89
A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders. Psychol Res Behav Manag (2015) 0.89
Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging Behav (2009) 0.88
Tourette Syndrome: Bridging the Gap between Genetics and Biology. Mol Neuropsychiatry (2015) 0.87
Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology (Berl) (2013) 0.87
Glutamate transporter gene (SLC1A1) single nucleotide polymorphism (rs301430) and repetitive behaviors and anxiety in children with autism spectrum disorder. J Autism Dev Disord (2010) 0.86
Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study. Psychiatry Res (2012) 0.86
DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS. Depress Anxiety (2015) 0.85
Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder. J Psychiatry Neurosci (2012) 0.85
Glutamate and the Treatment of Obsessive-Compulsive Disorder. Psychopharm Rev (2010) 0.83
Neuromodulation for obsessive-compulsive disorder. Neurotherapeutics (2014) 0.83
SLC1 glutamate transporters. Pflugers Arch (2013) 0.83
Expanding the Clinical Spectrum Associated With GLIS3 Mutations. J Clin Endocrinol Metab (2015) 0.81
Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder. Transl Psychiatry (2013) 0.81
mRNA for the EAAC1 subtype of glutamate transporter is present in neuronal dendrites in vitro and dramatically increases in vivo after a seizure. Neurochem Int (2010) 0.81
LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.80
Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system. Psychopharmacology (Berl) (2012) 0.80
The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases. J Alzheimers Dis (2013) 0.79
Neurochemicals measured by (1)H-MR spectroscopy: putative vulnerability biomarkers for obsessive compulsive disorder. MAGMA (2013) 0.79
Family-based association testing of glutamate transporter genes in autism. Psychiatr Genet (2011) 0.79
Translational neuroimaging research in pediatric obsessive-compulsive disorder. Dialogues Clin Neurosci (2010) 0.79
An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder. J Psychiatry Neurosci (2016) 0.78
A primary candidate gene for obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 0.78
Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial. J Res Med Sci (2014) 0.77
The Genetics of Obsessive-Compulsive Disorder. Curr Psychiatry Rev (2010) 0.77
Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions. J Psychiatry Neurosci (2012) 0.77
Long-term outcome in adults with obsessive-compulsive disorder. Depress Anxiety (2013) 0.77
OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior. Proc Natl Acad Sci U S A (2017) 0.77
High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. Neural Plast (2010) 0.76
Using mice to model Obsessive Compulsive Disorder: From genes to circuits. Neuroscience (2015) 0.76
Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models. Front Neurosci (2016) 0.75
Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36. Biol Psychiatry (2012) 0.75
NEUROBIOLOGICAL EVIDENCE SUPPORTING GLUTAMATE'S ROLE IN PEDIATRIC OBSESSIVE COMPULSIVE DISORDER. Child Adolesc Psychopharmacol News (2010) 0.75
The importance of the excitatory amino acid transporter 3 (EAAT3). Neurochem Int (2016) 0.75
DNA Methylation at the Neonatal State and at the Time of Diagnosis: Preliminary Support for an Association with the Estrogen Receptor 1, Gamma-Aminobutyric Acid B Receptor 1, and Myelin Oligodendrocyte Glycoprotein in Female Adolescent Patients with OCD. Front Psychiatry (2016) 0.75
Glutamatergic agents for OCD and related disorders. Curr Treat Options Psychiatry (2015) 0.75
OCDB: a database collecting genes, miRNAs and drugs for obsessive-compulsive disorder. Database (Oxford) (2015) 0.75
Glutamate modulators in the treatment of obsessive-compulsive disorder. Psychiatr Ann (2015) 0.75
Common variants of HTR3 genes are associated with obsessive-compulsive disorder and its phenotypic expression. Sci Rep (2016) 0.75
Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice. Biol Res (2017) 0.75
Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol (2017) 0.75
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull (2003) 2.76
Evidence that 'food addiction' is a valid phenotype of obesity. Appetite (2011) 2.02
The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet (2002) 1.98
Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment? Pharmacogenomics (2013) 1.97
Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study. Neurobiol Aging (2010) 1.77
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry (2002) 1.66
Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating. Obesity (Silver Spring) (2009) 1.65
Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res (2006) 1.64
Pharmacogenetics of psychotropic drug response. Am J Psychiatry (2004) 1.61
Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord (2003) 1.59
Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci (2005) 1.49
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berl) (2008) 1.46
Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments. Can J Psychiatry (2009) 1.45
Diffusion tensor tractography findings in schizophrenia across the adult lifespan. Brain (2010) 1.43
Connexin 50 gene on human chromosome 1q21 is associated with schizophrenia in matched case control and family-based studies. J Med Genet (2007) 1.42
Pharmacogenetics in psychiatry satellite meeting at the American College of Neuropsychopharmacology, 2000. Neuropsychopharmacology (2002) 1.39
Psychological treatment of obsessive-compulsive disorder in patients with major depression: a pilot randomized controlled trial. Can J Psychiatry (2009) 1.39
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) (2004) 1.39
Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.31
Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res (2003) 1.27
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology (2002) 1.23
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry (2012) 1.20
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels. Schizophr Res (2006) 1.18
Decision-making deficits and overeating: a risk model for obesity. Obes Res (2004) 1.16
Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity. Can J Psychiatry (2003) 1.15
Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia. Neuropsychobiology (2004) 1.10
Serotonin transporter polymorphisms and persistent, pervasive childhood aggression. Am J Psychiatry (2006) 1.08
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry (2004) 1.07
Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction (2009) 1.06
The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses. Neuropsychopharmacology (2011) 1.06
Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2005) 1.06
Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics (2006) 1.05
The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry (2011) 1.05
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. Pharmacogenomics (2010) 1.04
Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography. Neuroimage (2008) 1.04
Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms. Am J Med Genet B Neuropsychiatr Genet (2006) 1.04
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res (2009) 1.03
Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder. J Psychiatr Res (2006) 1.03
Personality and eating behaviors: a case-control study of binge eating disorder. Int J Eat Disord (2008) 1.03
Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol (2007) 1.02
Pharmacogenetics of antipsychotics. Can J Psychiatry (2014) 1.02
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett (2005) 1.02
Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. World J Biol Psychiatry (2009) 1.02
Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology (2006) 1.01
Association of attention-deficit/hyperactivity disorder with a candidate region for reading disabilities on chromosome 6p. Biol Psychiatry (2009) 1.01
A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis. Neuropsychopharmacology (2006) 0.99
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology (2010) 0.99
'Food addiction' and its association with a dopaminergic multilocus genetic profile. Physiol Behav (2013) 0.99
Pharmacogenomics in schizophrenia: the quest for individualized therapy. Hum Mol Genet (2002) 0.98
A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord (2008) 0.97
Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud (2007) 0.97
Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. Int J Neuropsychopharmacol (2005) 0.97
Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacology (2004) 0.97
Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. Arch Gen Psychiatry (2007) 0.97
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl) (2005) 0.97
Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia. Cereb Cortex (2012) 0.96
Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry (2006) 0.96
Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. PLoS One (2011) 0.96
Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder. Bipolar Disord (2008) 0.96
Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia. Exp Brain Res (2006) 0.96
Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 0.95
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet (2014) 0.95
Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology (2007) 0.94
Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.94
Association of the serotonin transporter and 5HT1Dbeta receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet (2004) 0.94
Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. Am J Med Genet B Neuropsychiatr Genet (2014) 0.94
Monoamine oxidase a gene is associated with borderline personality disorder. Psychiatr Genet (2007) 0.94
Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet (2010) 0.93
Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophr Res (2009) 0.92
Prenatal depression and 5-HTTLPR interact to predict dysregulation from 3 to 36 months--a differential susceptibility model. J Child Psychol Psychiatry (2014) 0.92
The dopamine D4 receptor gene and moderation of the association between externalizing behavior and IQ. Arch Gen Psychiatry (2006) 0.92
Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.91
The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet (2002) 0.91
Pharmacogenetics in drug development. Philos Trans R Soc Lond B Biol Sci (2005) 0.91
Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia. Eur Neuropsychopharmacol (2005) 0.91
Imaging phenotypes and genotypes in schizophrenia. Neuroinformatics (2006) 0.91
Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. Schizophr Res (2005) 0.90
Human p53 tumor suppressor gene (TP53) and schizophrenia: case-control and family studies. Neurosci Lett (2005) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology (Berl) (2005) 0.90
Genetics of antipsychotic-induced side effects and agranulocytosis. Curr Psychiatry Rep (2011) 0.90